| VX-445–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles D Keating, G Marigowda, L Burr, C Daines, MA Mall, EF McKone, ... New england journal of medicine 379 (17), 1612-1620, 2018 | 624 | 2018 |
| Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis CJ Hurson, JS Butler, DT Keating, DW Murray, DM Sadlier, JM O'Byrne, ... BMC musculoskeletal disorders 8, 1-12, 2007 | 109 | 2007 |
| Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years D Keating, B Levvey, T Kotsimbos, H Whitford, G Westall, T Williams, ... Transplantation proceedings 41 (1), 289-291, 2009 | 99 | 2009 |
| Improvement in exercise duration, lung function and well-being in G551D-cystic fibrosis patients: a double-blind, placebo-controlled, randomized, cross-over study with … D Edgeworth, D Keating, M Ellis, B Button, E Williams, D Clark, A Tierney, ... Clinical Science 131 (15), 2037-2045, 2017 | 76 | 2017 |
| Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFβ1 expression AP Malizia, DT Keating, SM Smith, D Walls, PP Doran, JJ Egan American Journal of Physiology-Lung Cellular and Molecular Physiology 295 (3 …, 2008 | 63 | 2008 |
| Diagnostic delay in pulmonary arterial hypertension: insights from the Australian and New Zealand pulmonary hypertension registry V Khou, JJ Anderson, G Strange, C Corrigan, N Collins, DS Celermajer, ... Respirology 25 (8), 863-871, 2020 | 61 | 2020 |
| Microarray identifies ADAM family members as key responders to TGF-β1 in alveolar epithelial cells DT Keating, DM Sadlier, A Patricelli, SM Smith, D Walls, JJ Egan, ... Respiratory research 7, 1-16, 2006 | 59 | 2006 |
| Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with … EK Schneider, F Reyes-Ortega, JW Wilson, T Kotsimbos, D Keating, J Li, ... Journal of Chromatography B 1038, 57-62, 2016 | 55 | 2016 |
| Cadaveric lobar lung transplantation: technical aspects SF Marasco, S Than, D Keating, G Westall, H Whitford, G Snell, J Gooi, ... The Annals of thoracic surgery 93 (6), 1836-1842, 2012 | 55 | 2012 |
| Advance directives for truth disclosure DT Keating, K Nayeem, JJ Gilmartin, S T O’Keeffe Chest 128 (2), 1037-1039, 2005 | 52 | 2005 |
| Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition AY Peleg, JM Choo, KM Langan, D Edgeworth, D Keating, J Wilson, ... Journal of Cystic Fibrosis 17 (1), 50-56, 2018 | 48 | 2018 |
| Long-term outcomes of cadaveric lobar lung transplantation: helping to maximize resources DT Keating, SF Marasco, J Negri, D Esmore, JH Burton, AP Griffiths, ... The Journal of heart and lung transplantation 29 (4), 439-444, 2010 | 35 | 2010 |
| Survival of idiopathic pulmonary arterial hypertension patients in the modern era in Australia and New Zealand G Strange, EM Lau, E Giannoulatou, C Corrigan, E Kotlyar, F Kermeen, ... Heart, Lung and Circulation 27 (11), 1368-1375, 2018 | 34 | 2018 |
| Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A … SJ King, AC Tierney, D Edgeworth, D Keating, E Williams, T Kotsimbos, ... Nutrition 85, 111124, 2021 | 30 | 2021 |
| Retrospective validation of the REVEAL 2.0 risk score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort JJ Anderson, EM Lau, M Lavender, R Benza, DS Celermajer, N Collins, ... Chest 157 (1), 162-172, 2020 | 30 | 2020 |
| VO2max as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trial J Wilson, X You, M Ellis, DS Urquhart, L Jha, M Duncan, S Tian, RA Harris, ... Journal of Cystic Fibrosis 20 (3), 499-505, 2021 | 20 | 2021 |
| Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients SC Heng, GI Snell, B Levvey, D Keating, GP Westall, TJ Williams, ... Antimicrobial agents and chemotherapy 57 (9), 4581-4583, 2013 | 18 | 2013 |
| Pulmonary arterial hypertension with below threshold pulmonary vascular resistance S Ratwatte, J Anderson, G Strange, C Corrigan, N Collins, DS Celermajer, ... European Respiratory Journal 56 (1), 2020 | 16 | 2020 |
| Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury Y Haider, AP Malizia, DT Keating, M Birch, A Tomlinson, G Martin, ... Journal of Inflammation 4, 1-14, 2007 | 15 | 2007 |
| Re-imagining cystic fibrosis care: next generation thinking C Rang, D Keating, J Wilson, T Kotsimbos European Respiratory Journal 55 (5), 2020 | 14 | 2020 |
John WilsonMonash UniversityVerified email at monash.edu
